US Patent 7964701 Alpha-fetoprotein peptides
Patent 7964701 was granted and assigned to Albany Medical College on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+347 characters)
Article
Patent abstract
The invention relates to compounds that include peptides that inhibit estrogen receptor dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Herbert Jacobson0
James A. Bennett0
Thomas T. Andersen0
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07964701 Alpha-fetoprotein peptides US Patent 7964701 Alpha-fetoprotein peptides
Infobox
Patent Number
079647010
Patent Number
79647010
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079647010
Date of Patent
June 21, 2011
0Patent Application Number
124106120
Date Filed
March 25, 2009
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07964701 Alpha-fetoprotein peptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07964701
Date of patent
June 21, 2011
Patent application number
12410612
Date Filed
March 25, 2009
Patent primary examiner
Find more entities like US Patent 7964701 Alpha-fetoprotein peptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
